oxidopamine has been researched along with Acute Pain in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Acute Pain: Intensely discomforting, distressful, or agonizing sensation associated with trauma or disease, with well-defined location, character, and timing.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vergara, F | 1 |
| Sardi, NF | 1 |
| Pescador, AC | 1 |
| Guaita, GO | 1 |
| Jark Stern, CA | 1 |
| Chichorro, JG | 1 |
| Fischer, L | 1 |
1 other study available for oxidopamine and Acute Pain
| Article | Year |
|---|---|
Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain.
Topics: Acute Pain; Analgesics, Opioid; Animals; Chronic Pain; Dinoprostone; Disease Progression; Dopamine; | 2020 |